Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EWTX | AMGN | VRTX | BMY | GILD |
| Company | Edgewise Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 30.05 | 265.18 | 467.06 | 57.35 | 92.72 |
| High | 31.41 | 267.19 | 471.05 | 58.55 | 93.50 |
| Low | 29.94 | 258.68 | 445.87 | 56.77 | 90.59 |
| Last | 30.01 | 258.78 | 447.50 | 56.84 | 90.69 |
| Change | -0.16 | -7.17 | -21.74 | -0.81 | -2.11 |
| % Change | -0.53% | -2.70% | -4.63% | -1.41% | -2.27% |
| Volume | 1,129,801 | 3,966,856 | 1,704,096 | 13,191,807 | 5,979,442 |
| 20-Day Average Volume | 811,824 | 4,550,469 | 1,221,859 | 9,461,848 | 6,291,666 |
| Previous Close | 30.17 | 265.95 | 469.24 | 57.65 | 92.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.18 | 277.78 | 462.40 | 58.13 | 91.74 |
| 20-Day Raw Stochastic | 38.71% | 7.49% | 11.22% | 39.27% | 52.62% |
| 20-Day Relative Strength | 47.87% | 28.27% | 41.58% | 52.42% | 52.26% |
| Weighted Alpha | +100.88 | -15.73 | +5.73 | +17.72 | +23.09 |
| Today's Opinion | 40% Buy | 88% Sell | 56% Sell | 80% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 24% Sell | 80% Buy | 100% Buy |
| Last Month's Opinion | 72% Buy | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.64% since 12/11/24 | -4.63% since 12/11/24 | -4.22% since 12/11/24 | +1.07% since 12/11/24 | -1.07% since 12/11/24 |
| Low | 27.00 on 12/12/24 | 260.61 on 12/18/24 | 447.98 on 12/18/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 |
| High | 35.50 on 12/16/24 | 275.88 on 12/12/24 | 474.18 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | -1.62% since 11/18/24 | -6.46% since 11/18/24 | -3.96% since 11/18/24 | +0.80% since 11/18/24 | +3.31% since 11/18/24 |
| Low | 27.00 on 12/12/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 55.04 on 12/13/24 | 86.08 on 11/19/24 |
| High | 35.50 on 12/16/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | +58.84% since 09/18/24 | -21.67% since 09/18/24 | -5.41% since 09/18/24 | +15.11% since 09/18/24 | +8.94% since 09/18/24 |
| Low | 24.84 on 09/19/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 48.94 on 09/19/24 | 81.83 on 09/26/24 |
| High | 38.12 on 11/11/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +87.21% since 06/18/24 | -14.78% since 06/18/24 | -4.01% since 06/18/24 | +40.30% since 06/18/24 | +44.72% since 06/18/24 |
| Low | 15.02 on 08/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 |
| High | 38.12 on 11/11/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,856,767 | 142,956,912 | 120,842,896 | 116,924,408 | 115,653,488 |
| Shares Outstanding, K | 94,689 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -100,160,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -34,130,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.12 | 0.55 | 0.36 | 0.45 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 11/07/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 02/04/25 | 02/03/25 | 02/06/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 01/03/25 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.87 | 0.00 | 47.75 | 20.78 |